Top diabetes drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

This statistic represents the top diabetes drugs in the United States, based on revenue between July 2011 and June 2012. In this period, diabetes drug Actos generated around 2.7 billion U.S. dollars of revenues.

Download this statistic as XLS, PPT, PNG and PDF?
Basic Account
  • Access to basic statistics
  • Download as XLS, PPT, PNG and PDF
Premium Account
  • All the advantages of the Basic Account
  • Instant access to all statistics
  • Easy integration into your projects
 Revenue in million U.S. dollars
Actos 2,736.4
Januvia 2,323.8
Lantus 2,064.7
Lantus Solostar 1,773.3
Novolog 1,073.7
Humalog 1,004.1
Levemir 947.8
Novolog Flexpen 897
Janumet 841.2
Victoza 3-Pak 587.9
You may also be interested in...
Show more
Recent Statistics
Related market forecasts
Related Reports
Health & Pharmaceuticals - Statistics & Facts

Find the proper statistic fast and easy: